Assignee profile:

QLT INC.

City:

Vancouver

Country:

Canada

Published Applications:

36

Last publication date:

2014-04-03

Patent Grants:

27

Last grant date:

2014-04-08

Top Inventors for applications by QLT INC.

These are the the leading inventors for applications assigned to QLT INC.:

Recent patent applications by QLT INC.

QLT INC. based in Vancouver, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-04-03
US20140094484A1
Human necessities

SUSTAINED DELIVERY FORMULATIONS OF RAPAMYCIN COMPOUNDS

#2 | 2013-04-25 ✅ Patent 8,691,265 granted on 2014-04-08
US20130101658A1
Human necessities

Drug delivery methods, structures, and compositions for nasolacrimal system

#3 | 2012-12-20 ✅ Patent 8,702,643 granted on 2014-04-22
US20120318281A1
Human necessities

Lacrimal implants and related methods

#4 | 2012-11-01
US20120277694A1
Human necessities

PUNCTAL PLUG WITH ACTIVE AGENT

#5 | 2012-09-27
US20120245682A1
Human necessities

SURFACE TREATED IMPLANTABLE ARTICLES AND RELATED METHODS

#6 | 2012-08-09 ✅ Patent 8,862,224 granted on 2014-10-14
US20120203162A1
Human necessities

Method for treating neovascularization

#7 | 2012-07-26 ✅ Patent 8,628,792 granted on 2014-01-14
US20120187594A1
Human necessities

Drug cores for sustained release of therapeutic agents

#8 | 2012-02-16 ✅ Patent 9,226,917 granted on 2016-01-05
US20120041356A1
Human necessities

Photodynamic therapy for conditions of the eye

#9 | 2012-01-31 ✅ Patent 8,106,038 granted on 2012-01-31
US10081010
-

Method for reducing or preventing PDT related inflammation

#10 | 2011-11-10 ✅ Patent 8,747,884 granted on 2014-06-10
US20110276131A1
Human necessities

Nasolacrimal drainage system implants for drug therapy

#11 | 2011-10-20 ✅ Patent 9,173,856 granted on 2015-11-03
US20110257266A1
Human necessities

Therapeutic regimen and methods for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency

#12 | 2010-07-15
US20100179218A1
Human necessities

OCULOSELECTIVE DRUGS AND PRODRUGS

#13 | 2010-07-13 ✅ Patent 7,753,943 granted on 2010-07-13
US10641885
-

Reduced fluence rate PDT

#14 | 2009-12-03 ✅ Patent 8,210,902 granted on 2012-07-03
US20090298390A1
Human necessities

Surface treated implantable articles and related methods

#15 | 2009-04-23 ✅ Patent 8,333,726 granted on 2012-12-18
US20090104248A1
Human necessities

Lacrimal implants and related methods

#16 | 2008-11-25 ✅ Patent 7,455,858 granted on 2008-11-25
US10440505
-

Compositions and methods for delivery of photosensitive drugs

#17 | 2008-04-24 ✅ Patent 8,158,669 granted on 2012-04-17
US20080096865A1
Human necessities

Method for treating neovascularization

#18 | 2008-04-24
US20080096857A1
Human necessities

Photodynamic Therapy For The Treatment Of Hyperactive Sebaceous Gland Disorders Using Topically Applied Hydrophobic Green Porphyrins

#19 | 2008-03-20
US20080071331A1
Human necessities

Photodynamic Therapy For The Treatment Of Prostatic Conditions

#20 | 2008-01-03 ✅ Patent 7,678,775 granted on 2010-03-16
US20080003217A1
Chemistry; metallurgy

ILK inhibitors for the treatment of renal disease

#21 | 2007-09-04 ✅ Patent 7,264,629 granted on 2007-09-04
US10422363
-

Photodynamic therapy for the treatment of hair loss

#22 | 2007-08-16
US20070191329A1
Chemistry; metallurgy

Ethylene glycol esters as photoactive agents

#23 | 2006-12-14
US20060281798A1
Chemistry; metallurgy

Methods of using thiazolidinedithione derivatives

#24 | 2006-11-23
US20060265028A1
Human necessities

Hair growth

#25 | 2006-11-02 ✅ Patent 7,847,101 granted on 2010-12-07
US20060247210A1
Chemistry; metallurgy

Pyrazolylbenzothiazole derivatives and their use as therapeutic agents

#26 | 2006-10-17 ✅ Patent 7,122,568 granted on 2006-10-17
US9715478
-

Use of low-dose PDT to inhibit restenosis

#27 | 2006-09-12 ✅ Patent 7,105,503 granted on 2006-09-12
US10077238
-

Pyrazole compounds

#28 | 2006-08-15 ✅ Patent 7,090,691 granted on 2006-08-15
US10291795
-

Photodynamic therapy for the treatment of hair loss

#29 | 2006-06-13 ✅ Patent 7,060,695 granted on 2006-06-13
US10072215
-

Method to prevent vision loss

#30 | 2006-04-04 ✅ Patent 7,022,702 granted on 2006-04-04
US10144203
-

Antiproliferative 1,2,3-thiadiazole compounds

#31 | 2006-03-21 ✅ Patent 7,015,240 granted on 2006-03-21
US10622310
-

Treatment of macular edema

#32 | 2006-01-12 ✅ Patent 7,288,556 granted on 2007-10-30
US20060009500A1
Human necessities

Antiproliferative 1,2,3-thiadiazole compounds

#33 | 2006-01-10 ✅ Patent 6,984,395 granted on 2006-01-10
US9833406
-

Drug delivery system for hydrophobic drugs

#34 | 2005-05-19 ✅ Patent 7,135,193 granted on 2006-11-14
US20050107329A1
Human necessities

Liposome compositions of porphyrin photosensitizers

#35 | 2005-05-10 ✅ Patent 6,890,555 granted on 2005-05-10
US9589358
-

Liposome compositions of porphyrin photosensitizers

#36 | 2005-02-01 ✅ Patent 6,849,058 granted on 2005-02-01
US9583392
-

Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases

AssigneeID:

19494 ⎘